AI Bias Analysis
4 models · Takes ~15 seconds
A cancer drug candidate that, rightly or wrongly, became a flashpoint at FDA, fails on a second try at approval.
Source
Stat News
Opens original article in a new tab
(MedPage Today) -- Welcome to Culture Clinic, MedPage Today's collaboration with Northwell Health to offer a healthcare professional's take on the latest viral medical topics. Adaptogens are having a moment, particularly in food and beverages...
(MedPage Today) -- President Donald Trump's administration this week acknowledged it made a significant error in figures it used to help justify a fraud probe into New York's Medicaid program, a glaring mistake that undercuts a federal campaign...
(MedPage Today) -- The addition of the AKT inhibitor capivasertib (Truqap) to abiraterone (Zytiga) and androgen deprivation therapy (ADT) improved radiographic progression-free survival (rPFS) in patients with PTEN-deficient metastatic hormone...
The Justice Department's actions on illegal vapes pales next to the scale of the problem, anti-smoking advocates say.
